Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care

BACKGROUND: MP-AzeFlu (Dymista®; spray of azelastine/fluticasone propionate) is the most effective allergic rhinitis (AR) treatment available. Its effect on asthma outcomes in patients with AR and asthma is unknown. METHODS: This pre-post historical cohort study, using the Optimum Patient Care Resea...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World Allergy Organ J
Glavni autori: De Jong, Hilda J.I., Voorham, Jaco, Scadding, Glenis K., Bachert, Claus, Canonica, Giorgio Walter, Smith, Peter, Wahn, Ulrich, Ryan, Dermot, Castillo, Jose A., Carter, Victoria A., Murray, Ruth B., Price, David B.
Format: Artigo
Jezik:Inglês
Izdano: World Allergy Organization 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753940/
https://ncbi.nlm.nih.gov/pubmed/33376573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2020.100490
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items